covid 19 News and Research

RSS
Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2

Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2

18 Apr 2022
Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

18 Apr 2022
Study predicts that different statins exhibit divergent effects on host response to SARS-CoV-2 infection

Study predicts that different statins exhibit divergent effects on host response to SARS-CoV-2 infection

18 Apr 2022
Novel approach estimates past SARS-CoV-2 daily infections, cumulative infections, and the proportion of the population infected

Novel approach estimates past SARS-CoV-2 daily infections, cumulative infections, and the proportion of the population infected

18 Apr 2022
Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

18 Apr 2022
Monoclonal antibodies from COVID-19 convalescent donors target conserved site

Monoclonal antibodies from COVID-19 convalescent donors target conserved site

18 Apr 2022
RNA interference triggers that target SARS-CoV-2 genome

RNA interference triggers that target SARS-CoV-2 genome

18 Apr 2022
SARS-CoV-2 infection patterns in olfactory epithelium

SARS-CoV-2 infection patterns in olfactory epithelium

18 Apr 2022
SARS-CoV-2 RBD is a selective integrin agonist

SARS-CoV-2 RBD is a selective integrin agonist

18 Apr 2022
Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

18 Apr 2022
Impact of COVID-19 booster vaccination campaign in Israel

Impact of COVID-19 booster vaccination campaign in Israel

18 Apr 2022
Delivery technologies of mRNA and pDNA for advanced therapeutic applications

Delivery technologies of mRNA and pDNA for advanced therapeutic applications

15 Apr 2022
Role of cGAS-STING in SARS-CoV-2 infection

Role of cGAS-STING in SARS-CoV-2 infection

15 Apr 2022
Durable neutralizing response against Omicron after heterologous vaccine boosting

Durable neutralizing response against Omicron after heterologous vaccine boosting

15 Apr 2022
Genomic characterization of the circulating SARS-CoV-2 lineages in Papua New Guinea

Genomic characterization of the circulating SARS-CoV-2 lineages in Papua New Guinea

15 Apr 2022
How the test-to-treat pillar of the US covid strategy is failing patients

How the test-to-treat pillar of the US covid strategy is failing patients

15 Apr 2022
Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

15 Apr 2022
Insight into the future of genetic testing

Insight into the future of genetic testing

From Natera 15 Apr 2022
Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

15 Apr 2022
Researchers track COVID-fighting antibodies after vaccination

Researchers track COVID-fighting antibodies after vaccination

15 Apr 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback